Use of Extracorporeal Membrane Oxygenation as a Bridge to Primary Lung Transplant: 3 Consecutive, Successful Cases and a Review of the Literature

2008 ◽  
Vol 27 (3) ◽  
pp. 348-352 ◽  
Author(s):  
Andrew Jackson ◽  
Jonathan Cropper ◽  
Roger Pye ◽  
Frank Junius ◽  
Monique Malouf ◽  
...  
2017 ◽  
Vol 7 (1) ◽  
Author(s):  
Pedro Vitale Mendes ◽  
Cesar de Albuquerque Gallo ◽  
Bruno Adler Maccagnan Pinheiro Besen ◽  
Adriana Sayuri Hirota ◽  
Raquel de Oliveira Nardi ◽  
...  

Perfusion ◽  
2019 ◽  
Vol 35 (3) ◽  
pp. 197-201
Author(s):  
Andrew Brazier ◽  
Edward Seville ◽  
Wesley Hesford ◽  
Bryce Pate ◽  
Paul Exton ◽  
...  

Extracorporeal membrane oxygenation is a safe modality of cardiorespiratory support for lung transplantation, with a reduction in coagulopathy and transfusion requirement when compared with cardiopulmonary bypass. In some scenarios, in lung transplantation, there are advantages to the use of cardiopulmonary bypass, which allows cardiac decompression, filtering of embolic air, easy addition and removal of volume, and a means to immediately reintroduce lost blood into circulation. We describe a novel circuit which allows safe and easy switch between modalities without prolonged interruption of flow. This circuit offers a safety net during surgery to minimise the risks influencing the use of extracorporeal membrane oxygenation.


2018 ◽  
Vol 54 (2) ◽  
pp. 341-347 ◽  
Author(s):  
Matthieu Glorion ◽  
Olaf Mercier ◽  
Delphine Mitilian ◽  
Alexandra De Lemos ◽  
Lilia Lamrani ◽  
...  

2021 ◽  
Vol 42 (03) ◽  
pp. 380-391
Author(s):  
John W. Stokes ◽  
Whitney D. Gannon ◽  
Matthew Bacchetta

AbstractExtracorporeal membrane oxygenation (ECMO) is a cardiopulmonary technology capable of supporting cardiac and respiratory function in the presence of end-stage lung disease. Initial experiences using ECMO as a bridge to lung transplant (ECMO-BTLT) were characterized by high rates of ECMO-associated complications and poor posttransplant outcomes. More recently, ECMO-BTLT has garnered success in preserving patients' physiologic condition and candidacy prior to lung transplant due to technological advances and improved management. Despite recent growth, clinical practice surrounding use of ECMO-BTLT remains variable, with little data to inform optimal patient selection and management. Although many questions remain, the use of ECMO-BTLT has shown promising outcomes suggesting that ECMO-BTLT can be an effective strategy to ensure that complex and rapidly decompensating patients with end-stage lung disease can be safely transplanted with good outcomes. Further studies are needed to refine and inform practice patterns, management, and lung allocation in this high-risk and fragile patient population.


Sign in / Sign up

Export Citation Format

Share Document